BCR and liver cancer: Syk, with a cancer linker degree of 17, found differentially expressed in 4 types of cancer and with a SF-Probability of 0.99, is a positive effector of BCR-stimulated responses [47] and has been found to be involved in urinary bladder carcinoma [48] and primary liver cancer [49].